Allworth Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203 Sell
3
-29
-91% -$2.64K ﹤0.01% 4920
2025
Q4
$4.18K Buy
32
+10
+45% +$1.37K ﹤0.01% 3818
2025
Q3
$2.37K Buy
+22
New +$2.4K ﹤0.01% 3921
2025
Q2
Sell
-5
Closed -$507 4679
2025
Q1
$507 Buy
+5
New +$434 ﹤0.01% 3670
2024
Q4
Sell
-2
Closed -$85 4045
2024
Q3
$85 Hold
2
﹤0.01% 3665
2024
Q2
$64 Sell
2
-4
-67% -$76 ﹤0.01% 3614
2024
Q1
$55 Hold
6
﹤0.01% 3532
2023
Q4
$17 Hold
6
﹤0.01% 3400
2023
Q3
$22 Hold
6
﹤0.01% 3388
2023
Q2
$36 Buy
6
+1
+20% +$8 ﹤0.01% 3203
2023
Q1
$59 Buy
5
+3
+150% +$40 ﹤0.01% 3119
2022
Q4
$16 Hold
2
﹤0.01% 2961
2022
Q3
$0 Buy
+2
New +$92 ﹤0.01% 3145

Other funds holding WGS

Allworth Financial's WGS Position: Q1 2026 in Review

Allworth Financial reduced its GeneDx Holdings (WGS) stake by 91% in Q1 2026, selling an estimated $2.64K and leaving 3 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #4920.

Allworth Financial first reported a position in WGS in Q3 2022 and has held it in 13 quarters since. The position peaked at $4.18K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Allworth Financial held 3 shares of GeneDx Holdings worth $203 as of Q1 2026.
  • Allworth Financial sold 29 GeneDx Holdings shares in Q1 2026, an estimated $2.64K.
  • GeneDx Holdings made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4920 holding.
  • Allworth Financial first reported a position in GeneDx Holdings in Q3 2022 and has held it in 13 quarters since.
  • Allworth Financial's GeneDx Holdings position peaked at $4.18K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.